MBOT Share Price | Microbot Medical, Inc. Stock Analysis & Recommendation

Q: What does Microbot Medical, Inc. do?

Overview:Microbot Medical, Inc. is a pre-clinical medical device company focused on the research, design, and development of robotic endoluminal surgery devices in the Pharmaceuticals & Biotechnology industry, with a market cap of USD 88.03 Million.Financial Snapshot:Most recent Net Profit: -3 Million (Quarterly Results - Mar 2025) Market cap: USD 88.03 Million (Micro Cap)Key Metrics:P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.05 Return on Equity: -40.32% Price to Book: 3.04Contact Details:Address: 25 RECREATION PARK DR SUITE 108, HINGHAM MA : 02043 Tel: 1 908 9385561 Fax: 1 302 6555049 Website: http://www.microbotmedical.com/

Q: Is Microbot Medical, Inc. technically bullish or bearish?

As of 3 September 2025, the technical trend for Microbot Medical, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands indicate a mildly bullish stance on both weekly and monthly time frames. The daily moving averages are also mildly bullish. However, the KST shows a mildly bearish trend on the weekly but bullish on the monthly, and Dow Theory indicates a mildly bearish trend on the weekly and mildly bullish on the monthly. The On-Balance Volume is bullish for both weekly and monthly periods.In terms of performance, the stock has significantly outperformed the S&P 500 year-to-date with a return of 175.89% compared to the S&P 500's 12.22%, and over the past year, it has returned 233.91% against the S&P 500's 17.14%. Overall, the current technical stance is bullish, driven primarily by the positive MACD and OBV indicators.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.2 M

Shareholding (Sep 2025)

FII

0.92%

Held by 18 FIIs

DII

90.2%

Held by 6 DIIs

Promoter

3.19%

How big is Microbot Medical, Inc.?

22-Jun-2025

As of Jun 18, Microbot Medical, Inc. has a market capitalization of 88.03 million, with net sales of 0.00 million and a net profit of -11.66 million over the latest four quarters. Shareholder's funds are 3.53 million, and total assets are 6.03 million as of Dec 24.

View full answer

What does Microbot Medical, Inc. do?

22-Jun-2025

Microbot Medical, Inc. is a pre-clinical medical device company specializing in robotic endoluminal surgery devices, with a market cap of USD 88.03 million and a recent net profit of -3 million. The company operates in the Pharmaceuticals & Biotechnology industry and currently does not pay dividends.

View full answer

Who are in the management team of Microbot Medical, Inc.?

22-Jun-2025

As of March 2022, the management team of Microbot Medical, Inc. is led by Mr. Harel Gadot, who is the Chairman, President, and CEO, alongside independent directors Mr. Yoseph Bornstein, Mr. Scott Burell, Mr. Prattipati Laxminarain, Mr. Martin Madden, and Ms. Aileen Stockburger.

View full answer

Is Microbot Medical, Inc. technically bullish or bearish?

20-Sep-2025

As of September 3, 2025, Microbot Medical, Inc. shows a bullish technical trend, supported by positive MACD and On-Balance Volume indicators, with a year-to-date return of 175.89% compared to the S&P 500's 12.22%.

View full answer

Compare Microbot Medical, Inc. with Similar Stocks

BiomX, Inc.AquaBounty Technologies, Inc.Elutia, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 136 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.02

Return on Equity

-16.71%

Price to Book

1.73

Revenue and Profits:

Net Sales:

(Quarterly Results - Sep 2025)

Net Profit:

-4 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

27.01%

6 Months

74.0%

1 Year

58.18%

2 Years

-33.33%

3 Years

-70.41%

4 Years

-77.31%

5 Years

-74.93%

Microbot Medical, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-22.49%

EBIT to Interest (avg)

-10.07

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.05

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

17.39%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.53

EV to EBIT

-5.86

EV to EBITDA

-5.90

EV to Capital Employed

-51.45

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-40.32%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 3 Schemes (5.69%)

Foreign Institutions

Held by 18 Foreign Institutions (0.92%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -12.50% vs -33.33% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.90",
          "val2": "-3.30",
          "chgp": "-18.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.60",
          "val2": "-3.20",
          "chgp": "-12.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -6.54% vs 18.94% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.50",
          "val2": "-9.70",
          "chgp": "-18.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.40",
          "val2": "-10.70",
          "chgp": "-6.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-3.90

-3.30

-18.18%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-3.60

-3.20

-12.50%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -12.50% vs -33.33% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-11.50

-9.70

-18.56%

Interest

0.00

Exceptional Items

0.00

-1.10

100.00%

Consolidate Net Profit

-11.40

-10.70

-6.54%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -6.54% vs 18.94% in Dec 2023

All Annual Results

Company CV

About Microbot Medical, Inc.

Microbot Medical, Inc.

Pharmaceuticals & Biotechnology

Microbot Medical Inc. is a pre-clinical medical device company. The Company is focused on the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms, ViRob, TipCAT and Liberty, including certain CardioSert assets, are comprised of proprietary technologies. Using the ViRob platform, Microbot is developing the Self Cleaning Shunt (SCSTM) for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH). Utilizing the Liberty and CardioSert platforms, it is developing disposable robot for various endovascular interventional procedures. ViRob technology is an autonomous crawling micro-robot. TipCAT is a disposable self-propelled locomotive device. Liberty is a disposable robotic system.

Company Coordinates

Company Details

25 RECREATION PARK DR SUITE 108 , HINGHAM MA : 02043

Tel: 1 908 9385561

http://www.microbotmedical.com/

Registrar Details

Microbot Medical, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Microbot Medical, Inc.?

Watch in Real-Time

What does Microbot Medical, Inc. do?

Who are in the management team of Microbot Medical, Inc.?

Is Microbot Medical, Inc. technically bullish or bearish?

Compare Microbot Medical, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Microbot Medical, Inc.

Company Coordinates